ストックスクリーナーアプリを入手
8.20
0.97%
-0.08
前日終値:
$8.28
開ける：
$8.37
24時間の取引高:
8,683
Relative Volume:
0.10
時価総額：
$289.75M
収益：
$4.71M
当期純損益:
$-46.77M
株価収益率:
-4.8833
EPS:
-1.6792
ネットキャッシュフロー:
$-60.34M
1週間 パフォーマンス:
+8.47%
1か月 パフォーマンス:
+6.22%
6か月 パフォーマンス:
-24.84%
1年 パフォーマンス:
-9.96%
1日の値動き範囲:
$8.10
$8.37
1週間の範囲:
$7.52
$8.37
52週間の値動き範囲:
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
NYXH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
8.14 | 289.75M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
514.28 | 188.55B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.52 | 50.87B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.09 | 43.87B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
257.05 | 37.84B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
207.25 | 16.47B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-31 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2022-04-21 | 開始されました | Oppenheimer | Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2021-12-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Nyxoah Sa (NYXH) 最新ニュース
Nyxoah SA Stock Analysis and ForecastPhenomenal returns - Jammu Links News
What analysts say about Nyxoah SA stockExceptional trading performance - Jammu Links News
Is Nyxoah SA stock a growth or value playFree Stock Market Forums - Newser
What makes Nyxoah SA stock price move sharplyShort Squeeze Radar - Newser
Why Nyxoah SA stock attracts strong analyst attentionFree Access to Investment Community - Newser
How Nyxoah SA stock performs during market volatilitySmart High Yield Swing Trades - Newser
(NYXH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025 - Yahoo
Major Governance Shift: Nyxoah Grants Long-term Shareholders New Board Nomination Rights - Stock Titan
Cantor Fitzgerald Forecasts Nyxoah FY2026 Earnings - Defense World
Ameriprise Financial Inc. Takes $135,000 Position in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
When the Price of (NYXH) Talks, People Listen - news.stocktradersdaily.com
Top Premarket Decliners - marketscreener.com
Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Nyxoah Announces Change in Shareholder Voting Rights - TipRanks
Vestal Point Capital Cuts Nyxoah Holdings by 40%: Major Ownership Shift Revealed - Stock Titan
Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times
Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan
Nyxoah SA Updates Share Capital and Voting Rights - TipRanks
Information on the total number of voting rights and shares - Yahoo
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World
Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria
Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com
Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN
Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com
Nyxoah Sa’s Earnings Call: Progress Amid Challenges - TipRanks
Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call Transcript - Insider Monkey
Nyxoah Reports Q1 2025 Financial Results and FDA Progress - TipRanks
Nyxoah Q1 2025 Earnings Call Transcript - MarketBeat
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results - TipRanks
Nyxoah (NYXH) Nears FDA Approval for Genio System in the U.S. | - GuruFocus
Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year - TipRanks
Nyxoah Reports First Quarter Financial and Operating Results - The Manila Times
Nyxoah Nears FDA Approval for Sleep Apnea Device as Q1 Revenue Hits €1.1M | NYXH Stock News - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH - Bluefield Daily Telegraph
Earnings To Watch: Nyxoah SA (NYXH) Reports Q1 2025 Result - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Nyxoah (NYXH) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Publication relating to transparency notifications - Stock Titan
Nyxoah SA Schedules Shareholders’ Meetings for June 2025 - TipRanks
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 - Yahoo Finance
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times
Nyxoah Sa (NYXH) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
0.31%
大文字化:
|
ボリューム (24 時間):